𝔖 Bobbio Scriptorium
✦   LIBER   ✦

[SpringerBriefs in Biotech Patents] Limits of Patentability || The Limits of Patentability: Genes and Nucleic Acids

✍ Scribed by Hübel, Andreas; Storz, Ulrich; Hüttermann, Aloys


Book ID
120036231
Publisher
Springer Berlin Heidelberg
Year
2012
Tongue
German
Weight
221 KB
Edition
2013
Category
Article
ISBN
3642328415

No coin nor oath required. For personal study only.

✦ Synopsis


SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer’s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids.


📜 SIMILAR VOLUMES


[SpringerBriefs in Biotech Patents] Limi
✍ Hübel, Andreas; Storz, Ulrich; Hüttermann, Aloys 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 161 KB

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section

[SpringerBriefs in Biotech Patents] Limi
✍ Hübel, Andreas; Storz, Ulrich; Hüttermann, Aloys 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 450 KB

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section